Pursuant to Regulation 29 read with Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ipca Laboratories has informed that a meeting of the Board of Directors of the Company will be held on Thursday, 13th February, 2025, to consider and take on record the Standalone and Consolidated Unaudited Financial Results for the 3rd quarter and nine months ended 31st December, 2024. Further, with reference to the above meeting of the Board of Directors, it has already informed vide its letter dated 26th December, 2024 that the trading window for dealing in the securities of the Company by the Insiders as defined under the SEBI (Prohibition of Insider Trading) Regulations, 2015 shall remain closed with effect from 1st January, 2025 and until 48 hours after the declaration of the Company’s unaudited financial results for the 3rd quarter and nine months ended 31st December, 2024 of the financial year 2024-25, till 15th February, 2025.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1735.45 |
Dr. Reddys Lab | 1144.05 |
Cipla | 1441.70 |
Lupin | 2026.50 |
Zydus Lifesciences | 885.70 |
View more.. |